Selected Properties of the Cytoskeletal Protein Synemin and Its Interactions with Proteins at the Muscle Z-Line Stephan Roman Bilak Iowa State University
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy
Journal of Clinical Medicine Review Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy Matthias Eden 1,2 and Norbert Frey 1,2,* 1 Department of Internal Medicine III, University of Heidelberg, 69120 Heidelberg, Germany; [email protected] 2 German Centre for Cardiovascular Research, Partner Site Heidelberg, 69120 Heidelberg, Germany * Correspondence: [email protected] Abstract: Over the past decades, there has been tremendous progress in understanding genetic alterations that can result in different phenotypes of human cardiomyopathies. More than a thousand mutations in various genes have been identified, indicating that distinct genetic alterations, or combi- nations of genetic alterations, can cause either hypertrophic (HCM), dilated (DCM), restrictive (RCM), or arrhythmogenic cardiomyopathies (ARVC). Translation of these results from “bench to bedside” can potentially group affected patients according to their molecular etiology and identify subclinical individuals at high risk for developing cardiomyopathy or patients with overt phenotypes at high risk for cardiac deterioration or sudden cardiac death. These advances provide not only mechanistic insights into the earliest manifestations of cardiomyopathy, but such efforts also hold the promise that mutation-specific pathophysiology might result in novel “personalized” therapeutic possibilities. Recently, the FLNC gene encoding the sarcomeric protein filamin C has gained special interest since FLNC mutations were found in several distinct and possibly overlapping cardiomyopathy phenotypes. Specifically, mutations in FLNC were initially only linked to myofibrillar myopathy (MFM), but are now increasingly found in various forms of human cardiomyopathy. FLNC thereby Citation: Eden, M.; Frey, N. Cardiac represents another example for the complex genetic and phenotypic continuum of these diseases. -
Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular
JACC: BASIC TO TRANSLATIONAL SCIENCE VOL.4,NO.7,2019 ª 2019 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE (http://creativecommons.org/licenses/by-nc-nd/4.0/). PRECLINICAL RESEARCH Gene Therapy Rescues Cardiac DysfunctioninDuchenneMuscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate a b c d,e Stephen C. Kolwicz, JR,PHD, John K. Hall, PHD, Farid Moussavi-Harami, MD, Xiolan Chen, PHD, d,e b,d,e e,f,g, b,e,g, Stephen D. Hauschka, PHD, Jeffrey S. Chamberlain, PHD, Michael Regnier, PHD, * Guy L. Odom, PHD * VISUAL ABSTRACT Kolwicz, S.C. Jr. et al. J Am Coll Cardiol Basic Trans Science. 2019;4(7):778–91. HIGHLIGHTS rAAV vectors increase cardiac-specific expression of RNR and elevate cardiomyocyte 2-dATP levels. Elevated myocardial RNR and subsequent increase in 2-dATP rescues the performance of failing myocardium, an effect that persists long term. ISSN 2452-302X https://doi.org/10.1016/j.jacbts.2019.06.006 JACC: BASIC TO TRANSLATIONAL SCIENCE VOL. 4, NO. 7, 2019 Kolwicz, Jr., et al. 779 NOVEMBER 2019:778– 91 Nucleotide-Based Cardiac Gene Therapy Restores Function in dmd Mice We show the ability to increase both cardiac baseline function and high workload contractile performance in ABBREVIATIONS aged (22- to 24-month old) mdx4cv mice, by high-level muscle-specific expression of either microdystrophin AND ACRONYMS or RNR. mDys = microdystrophin Five months post-treatment, mice systemically injected with rAAV6 vector carrying a striated muscle-specific CK8 regulatory cassette driving expression of microdystrophin in both skeletal and cardiac muscle, exhibited the = miniaturized murine creatine kinase regulatory greatest effect on systolic function. -
Postmortem Changes in the Myofibrillar and Other Cytoskeletal Proteins in Muscle
BIOCHEMISTRY - IMPACT ON MEAT TENDERNESS Postmortem Changes in the Myofibrillar and Other C'oskeletal Proteins in Muscle RICHARD M. ROBSON*, ELISABETH HUFF-LONERGAN', FREDERICK C. PARRISH, JR., CHIUNG-YING HO, MARVIN H. STROMER, TED W. HUIATT, ROBERT M. BELLIN and SUZANNE W. SERNETT introduction filaments (titin), and integral Z-line region (a-actinin, Cap Z), as well as proteins of the intermediate filaments (desmin, The cytoskeleton of "typical" vertebrate cells contains paranemin, and synemin), Z-line periphery (filamin) and three protein filament systems, namely the -7-nm diameter costameres underlying the cell membrane (filamin, actin-containing microfilaments, the -1 0-nm diameter in- dystrophin, talin, and vinculin) are listed along with an esti- termediate filaments (IFs), and the -23-nm diameter tubu- mate of their abundance, approximate molecular weights, lin-containing microtubules (Robson, 1989, 1995; Robson and number of subunits per molecule. Because the myofibrils et al., 1991 ).The contractile myofibrils, which are by far the are the overwhelming components of the skeletal muscle cell major components of developed skeletal muscle cells and cytoskeleton, the approximate percentages of the cytoskel- are responsible for most of the desirable qualities of muscle eton listed for the myofibrillar proteins (e.g., myosin, actin, foods (Robson et al., 1981,1984, 1991 1, can be considered tropomyosin, a-actinin, etc.) also would represent their ap- the highly expanded corollary of the microfilament system proximate percentages of total myofibrillar protein. of non-muscle cells. The myofibrils, IFs, cell membrane skel- eton (complex protein-lattice subjacent to the sarcolemma), Some Important Characteristics, Possible and attachment sites connecting these elements will be con- Roles, and Postmortem Changes of Key sidered as comprising the muscle cell cytoskeleton in this Cytoskeletal Proteins review. -
Functional Analysis of Tropomyosin Isoforms in Vivo
FUNCTIONAL ANALYSIS OF TROPOMYOSIN ISOFORMS IN VIVO by Aeri Cho A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland March, 2015 Abstract Precise regulation of a dynamic actin cytoskeleton is an essential function of animal cells without which vesicle trafficking, cytokinesis, cell adhesion and cell movement would be impossible. Therefore, understanding the mechanisms underlying actin dynamics is fundamental for understanding basic cellular biology as well as gaining insight into mechanisms of embryonic development, tissue homeostasis and regeneration, and pathological processes such as inflammation and tumor metastasis. Actin filaments are a major source of the protrusive and contractile forces that drive many cellular behaviors. Contractile forces require the action of non-muscle myosin II, which assembles onto actin filaments to form acto-myosin. The interaction between actin and myosin can occur spontaneously in vitro, but in cells it is regulated by accessory proteins including Tropomyosins (Tms). A complete understanding of Tm function has been elusive due in part to the large number of isoforms: 44 predicted isoforms from 4 genes in humans. The goal of this study was to decipher the functional roles of different Tm isoforms at the molecular, cellular and tissue levels in vivo. Drosophila egg chambers are a genetically tractable system that expresses far fewer Tm isoforms than mammalian cells. We identified three tropomyosin isoforms expressed in follicle cells, including one previously annotated as muscle-specific. We generated and characterized isoform- specific antibodies, RNAi lines, and mutant alleles, and discovered that they function non-redundantly in the two cell types we studied: border cells, a well-studied example of collective migration, and epithelial follicle cells, which develop contractile stress fibers that shape the egg chamber. -
Titin N2A Domain and Its Interactions at the Sarcomere
International Journal of Molecular Sciences Review Titin N2A Domain and Its Interactions at the Sarcomere Adeleye O. Adewale and Young-Hoon Ahn * Department of Chemistry, Wayne State University, Detroit, MI 48202, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-(313)-577-1384 Abstract: Titin is a giant protein in the sarcomere that plays an essential role in muscle contraction with actin and myosin filaments. However, its utility goes beyond mechanical functions, extending to versatile and complex roles in sarcomere organization and maintenance, passive force, mechanosens- ing, and signaling. Titin’s multiple functions are in part attributed to its large size and modular structures that interact with a myriad of protein partners. Among titin’s domains, the N2A element is one of titin’s unique segments that contributes to titin’s functions in compliance, contraction, structural stability, and signaling via protein–protein interactions with actin filament, chaperones, stress-sensing proteins, and proteases. Considering the significance of N2A, this review highlights structural conformations of N2A, its predisposition for protein–protein interactions, and its multiple interacting protein partners that allow the modulation of titin’s biological effects. Lastly, the nature of N2A for interactions with chaperones and proteases is included, presenting it as an important node that impacts titin’s structural and functional integrity. Keywords: titin; N2A domain; protein–protein interaction 1. Introduction Citation: Adewale, A.O.; Ahn, Y.-H. The complexity of striated muscle is defined by the intricate organization of its com- Titin N2A Domain and Its ponents [1]. The involuntary cardiac and voluntary skeletal muscles are the primary types Interactions at the Sarcomere. -
Tropomyosin) Using Food Processing Methods Adeseye Lasekan University of Maine, [email protected]
The University of Maine DigitalCommons@UMaine Electronic Theses and Dissertations Fogler Library Summer 8-11-2017 Attenuating the Antibody Reactivity of the Shrimp Major Allergen (Tropomyosin) using Food Processing Methods Adeseye Lasekan University of Maine, [email protected] Follow this and additional works at: http://digitalcommons.library.umaine.edu/etd Part of the Food Chemistry Commons, Food Processing Commons, and the Other Food Science Commons Recommended Citation Lasekan, Adeseye, "Attenuating the Antibody Reactivity of the Shrimp Major Allergen (Tropomyosin) using Food Processing Methods" (2017). Electronic Theses and Dissertations. 2732. http://digitalcommons.library.umaine.edu/etd/2732 This Open-Access Dissertation is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of DigitalCommons@UMaine. For more information, please contact [email protected]. ATTENUATING THE ANTIBODY REACTIVITY OF THE SHRIMP MAJOR ALLERGEN (TROPOMYOSIN) USING FOOD PROCESSING METHODS By Adeseye O. Lasekan B.Sc. Federal University of Agriculture Abeokuta, 2007 M.S. Universiti Putra Malaysia, 2013 A DISSERTATION Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy (in Food and Nutrition Sciences) The Graduate School The University of Maine August 2017 Advisory Committee: Balunkeswar Nayak, Assistant Professor of Food Processing, Advisor Soheila Maleki, Lead Scientist, USDA-ARS, Southern Regional Research Center Dorothy Klimis-Zacas, Professor of Clinical Nutrition Eric Gallandt, Professor of Weed Ecology Denise Skonberg, Associate Professor of Food Science Vivian Wu, Research Leader, USDA-ARS, Western Regional Research Center © 2017 Adeseye O. Lasekan All Rights Reserved ii ATTENUATING THE ANTIBODY REACTIVITY OF THE SHRIMP MAJOR ALLERGEN (TROPOMYOSIN) USING FOOD PROCESSING METHODS By Adeseye Lasekan Dissertation Advisor: Dr. -
TNNT2 Mutations in the Tropomyosin Binding Region of TNT1 Disrupt Its Role in Contractile Inhibition and Stimulate Cardiac Dysfunction
TNNT2 mutations in the tropomyosin binding region of TNT1 disrupt its role in contractile inhibition and stimulate cardiac dysfunction Aditi Madana, Meera C. Viswanathana, Kathleen C. Woulfeb, William Schmidta, Agnes Sidora, Ting Liua, Tran H. Nguyena, Bosco Trinhc, Cortney Wilsonb, Sineej Madathild, Georg Voglerc, Brian O’Rourkea, Brandon J. Biesiadeckie,f, Larry S. Tobacmand, and Anthony Cammaratoa,g,1 aDepartment of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD 21205; bDepartment of Medicine, Division of Cardiology, University of Colorado Denver, Aurora, CO 80045; cDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037; dDepartment of Medicine, University of Illinois College of Medicine, Chicago, IL 60612; eDepartment of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210; fThe Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210; and gDepartment of Physiology, Johns Hopkins University, Baltimore, MD 21205 Edited by Edwin W. Taylor, The University of Chicago, Chicago, IL, and approved June 15, 2020 (received for review January 28, 2020) Muscle contraction is regulated by the movement of end-to-end- “closed” C-state position, which partially uncovers myosin binding linked troponin−tropomyosin complexes over the thin filament sur- sites. Subsequent binding of a small population of myosin cross- face, which uncovers or blocks myosin binding sites along F-actin. bridges further displaces Tpm to an “open” M-state position, The N-terminal half of troponin T (TnT), TNT1, independently pro- completely exposing neighboring binding sites, leading to coop- motes tropomyosin-based, steric inhibition of acto-myosin associa- erative, full filament activation. -
Critical Review
IUBMB Life, 61(4): 394–406, April 2009 Critical Review A-kinase Anchoring Proteins: From Protein Complexes to Physiology and Disease Graeme K. Carnegie, Christopher K. Means and John D. Scott Howard Hughes Medical Institute, Department of Pharmacology, University of Washington, School of Medicine, Seattle, Washington, USA or a receptor tyrosine kinase or phosphatase), which results in Summary activation of the receptor or the mobilization of receptor-associ- Protein scaffold complexes are a key mechanism by which a ated proteins to generate some form of intracellular message. common signaling pathway can serve many different functions. There has been a concerted research effort focused to under- Sequestering a signaling enzyme to a specific subcellular envi- stand how the subcellular location of protein kinases and phos- ronment not only ensures that the enzyme is near its relevant targets, but also segregates this activity to prevent indiscrimi- phatases contributes to the regulation of phosphorylation events. nate phosphorylation of other substrates. One family of diverse, Sequestering a signaling enzyme to a specific subcellular envi- well-studied scaffolding proteins are the A-kinase anchoring ronment not only ensures that the enzyme is near to its relevant proteins (AKAPs). These anchoring proteins form multi-protein targets, but also segregates this activity to prevent indiscrimi- complexes that integrate cAMP signaling with other pathways nate phosphorylation of other substrates. Thus protein scaffold and signaling events. In this review, we focus on recent advan- complexes are a key mechanism, by which a common signaling ces in the elucidation of AKAP function. Ó 2009 IUBMB IUBMB Life, 61(4): 394–406, 2009 pathway can serve many different functions. -
Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach
International Journal of Molecular Sciences Review Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach Diana Cimiotti 1,* , Heidi Budde 2, Roua Hassoun 2 and Kornelia Jaquet 2,* 1 Department of Clinical Pharmacology, Ruhr-University Bochum, 44801 Bochum, Germany 2 Experimental and Molecular Cardiology, St. Josef Hospital and BG Bergmannsheil, Clinics of the Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] (H.B.); [email protected] (R.H.) * Correspondence: [email protected] (D.C.); [email protected] (K.J.); Tel.: +49-234-32-27639 (D.C.) Abstract: The sarcomere as the smallest contractile unit is prone to alterations in its functional, structural and associated proteins. Sarcomeric dysfunction leads to heart failure or cardiomyopathies like hypertrophic (HCM) or restrictive cardiomyopathy (RCM) etc. Genetic based RCM, a very rare but severe disease with a high mortality rate, might be induced by mutations in genes of non- sarcomeric, sarcomeric and sarcomere associated proteins. In this review, we discuss the functional effects in correlation to the phenotype and present an integrated model for the development of genetic RCM. Keywords: cardiomyopathy; restrictive cardiomyopathy; pediatric; sarcomere; contractile dysfunc- tion; calcium; aggregation; gene expression 1. The Sarcomere The sarcomere as the substructure of myofibrils is the contractile unit of striated muscles i.e. skeletal and cardiac muscle (Figure1). It forms a symmetric unit with the Citation: Cimiotti, D.; Budde, H.; M-disc in the center and is bordered by the Z-discs. M-disc and Z-disc provide the anchors Hassoun, R.; Jaquet, K. Genetic for thin, thick and elastic filaments. The elastic filament is composed of the giant protein Restrictive Cardiomyopathy: Causes and Consequences—An Integrative titin spanning half the sarcomere. -
Tropomyosin Movement Is Described by a Quantitative High‑Resolution Model of X‑Ray Diffraction of Contracting Muscle
This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Tropomyosin movement is described by a quantitative high‑resolution model of X‑ray diffraction of contracting muscle Koubassova, Natalia A.; Bershitsky, Sergey Y.; Ferenczi, Michael Alan; Narayanan, Theyencheri; Tsaturyan, Andrey K. 2016 Koubassova, N. A., Bershitsky, S. Y., Ferenczi, M. A., Narayanan, T., & Tsaturyan, A. K. (2017). Tropomyosin movement is described by a quantitative high‑resolution model of X‑ray diffraction of contracting muscle. European Biophysics Journal, 46(4), 335‑342. https://hdl.handle.net/10356/82598 https://doi.org/10.1007/s00249‑016‑1174‑6 © 2016 European Biophysical Societies' Association. This is the author created version of a work that has been peer reviewed and accepted for publication in European Biophysics Journal, published by Springer Berlin Heidelberg on behalf of European Biophysical Societies' Association. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1007/s00249‑016‑1174‑6]. Downloaded on 26 Sep 2021 21:50:01 SGT Tropomyosin movement is described by a quantitative high resolution model of x- ray diffraction of contracting muscle Pre-publication : not for distribution Koubassova N.A.1, Bershitsky S.Y.2, Ferenczi M.A.3, Narayanan T.4, Tsaturyan A.K.1 1Institute of Mechanics, M.V. Lomonosov Moscow University, Moscow, Russia; 2Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, Yekaterinburg, Russia; 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore 4European Synchrotron Radiation Facility, Grenoble, France Contact information: Dr. -
Tropomyosin (CH1): Sc-58868
SANTA CRUZ BIOTECHNOLOGY, INC. Tropomyosin (CH1): sc-58868 BACKGROUND STORAGE Tropomyosins are a group of structural proteins. Tropomyosins are present in Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of virtually all eukaryotic cells, both muscle and non-muscle, where they bind shipment. Non-hazardous. No MSDS required. Actin filaments and function to modulate Actin-Myosin interaction and stabi- lize Actin filament structure. Tropomyosin α is encoded by the TPM1 gene, DATA which maps to human chromosome 15q22.2 and undergoes alternative splic- ing to generate at least four isoforms, including skeletal muscle (isoform 1), AB CD 52 K – smooth muscle (isoform 2), fibroblast/TM3 (isoform 3) and isoform 4. 55 K – Tropomyosin β is encoded by the TPM2 gene, which maps to human chromo- < Tropomyosin some 9p13.3 and undergoes alternative splicing to generate three isoforms, 43 K – 35 K – including skeletal muscle (isoform 1), non-muscle/fibroblast TM36/epithelial Tropomyosin TMe1 (isoform 2) and non-muscle (isoform 3). Troponin I binds Tropomyosin 34K– 21K– at a specific region and the association of Tropomyosin-Troponin with Actin filaments may increase the rigidity of Actin filaments. Tropomyosin also interacts with Caldesmon to regulate smooth muscle contraction. Tropomyosin (CH1): sc-58868. Western blot analysisof Tropomyosin (CH1): sc-58868. Western blot analysisof Tropomyosin expressioninL8(A)wholecell lysate, rat Tropomyosin expressioninrat hearttissueextract. skeletal muscle (B), and human heart (C,D) tissue CHROMOSOMAL LOCATION extract, underreducing (A,B,C)andnon-reducing (D) conditions. Genetic locus: TPM1 (human) mapping to 15q22.2; Tpm1 (mouse) mapping to 9 C. SELECT PRODUCT CITATIONS 1. -
Muscle Diseases: the Muscular Dystrophies
ANRV295-PM02-04 ARI 13 December 2006 2:57 Muscle Diseases: The Muscular Dystrophies Elizabeth M. McNally and Peter Pytel Department of Medicine, Section of Cardiology, University of Chicago, Chicago, Illinois 60637; email: [email protected] Department of Pathology, University of Chicago, Chicago, Illinois 60637; email: [email protected] Annu. Rev. Pathol. Mech. Dis. 2007. Key Words 2:87–109 myotonia, sarcopenia, muscle regeneration, dystrophin, lamin A/C, The Annual Review of Pathology: Mechanisms of Disease is online at nucleotide repeat expansion pathmechdis.annualreviews.org Abstract by Drexel University on 01/13/13. For personal use only. This article’s doi: 10.1146/annurev.pathol.2.010506.091936 Dystrophic muscle disease can occur at any age. Early- or childhood- onset muscular dystrophies may be associated with profound loss Copyright c 2007 by Annual Reviews. All rights reserved of muscle function, affecting ambulation, posture, and cardiac and respiratory function. Late-onset muscular dystrophies or myopathies 1553-4006/07/0228-0087$20.00 Annu. Rev. Pathol. Mech. Dis. 2007.2:87-109. Downloaded from www.annualreviews.org may be mild and associated with slight weakness and an inability to increase muscle mass. The phenotype of muscular dystrophy is an endpoint that arises from a diverse set of genetic pathways. Genes associated with muscular dystrophies encode proteins of the plasma membrane and extracellular matrix, and the sarcomere and Z band, as well as nuclear membrane components. Because muscle has such distinctive structural and regenerative properties, many of the genes implicated in these disorders target pathways unique to muscle or more highly expressed in muscle.